Welcome to LookChem.com Sign In|Join Free
  • or
ETHYL[(1-METHYLPYRROLIDIN-2-YL)METHYL]AMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

68339-47-9

Post Buying Request

68339-47-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68339-47-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 68339-47-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,3,3 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 68339-47:
(7*6)+(6*8)+(5*3)+(4*3)+(3*9)+(2*4)+(1*7)=159
159 % 10 = 9
So 68339-47-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H18N2/c1-3-9-7-8-5-4-6-10(8)2/h8-9H,3-7H2,1-2H3

68339-47-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[(1-methylpyrrolidin-2-yl)methyl]ethanamine

1.2 Other means of identification

Product number -
Other names N-[(1-methyl-2-pyrrolidinyl)methyl]ethanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68339-47-9 SDS

68339-47-9Upstream product

68339-47-9Downstream Products

68339-47-9Relevant academic research and scientific papers

INHIBITORS OF HISTONE DEMETHYLASES

-

Page/Page column 150, (2014/09/16)

Compounds of the form In which Q is selected from -CH=NR12, –W, -CH=2NHR13, –CH=O and -CH(OR17)2 capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 68339-47-9